CytoSorbents Regains Nasdaq Compliance

CytoSorbents Corporation (NASDAQ: CTSO) has regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per share. The company specializes in blood purification treatments for critical conditions in intensive care and cardiac surgery.